VEGFA and acute respiratory distress syndrome: From experimental results, at ultra-early ALI stage, ulinastatin can mitigate vascular endothelial injury, reduce serum VEGF content and elevation level of pulmonary vascular permeability, lower migration and infiltration of inflammatory cells, thereby reducing the degree of lung injury and playing a role in lung protection.